Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis
Open Access
- 1 February 2006
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (2), 395-399
- https://doi.org/10.1128/jcm.44.2.595-597.2006
Abstract
The aim of this study was to determine if gastroenteric viruses were present on surfaces and equipment in a pediatric primary immunodeficiency unit (PPIU) by environmental sampling using swabs and subsequent nucleic acid extraction and reverse transcriptase PCR assays. A PPIU was chosen, and 11 swabs were taken at the same sites every 2 weeks for 6 months. Nested/heminested PCR assays were used to screen for astroviruses (AsV), noroviruses (NoV), and rotaviruses (RV). AsV, NoV, and RV were detected at multiple swab sites during the study period. NoV was the most frequently detected virus on environmental surfaces; however, RV was detected on 79% and NoV on 50% of swabbing dates during the study period. Toilet taps were the most contaminated sites. Fecal samples from selected patients in the unit were also screened during the study period, and patients excreted AsV, NoV, and RV at times during the study. New cleaning schedules and changes in some of the PPIU sanitary furniture have been suggested as a means of reducing environmental contamination.Keywords
This publication has 14 references indexed in Scilit:
- Daptomycin‐Resistant, Methicillin‐ResistantStaphylococcus aureusBacteremiaClinical Infectious Diseases, 2005
- Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infectionsJournal of Antimicrobial Chemotherapy, 2005
- Impact of High-InoculumStaphylococcus aureuson the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic ModelAntimicrobial Agents and Chemotherapy, 2004
- Principles of antimicrobial therapy in the transplant patientTransplant Infectious Disease, 2004
- The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure InfectionsClinical Infectious Diseases, 2004
- Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive PathogensClinical Infectious Diseases, 2004
- Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organismsJournal of Antimicrobial Chemotherapy, 2004
- In VitroActivities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a Challenge Panel of Staphylococci and Enterococci, Including Vancomycin-IntermediateStaphylococcus aureusand Vancomycin-ResistantEnterococcus faeciumMicrobial Drug Resistance, 2003
- Resistance Studies with DaptomycinAntimicrobial Agents and Chemotherapy, 2001
- Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbitsAntimicrobial Agents and Chemotherapy, 1989